The Commission's Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) opened a call for evidence on phtalates in medical devices.

The SCHEERis updating the guidelines on the benefit-risk assessment of phthalates present in certain medical devices.

This applies to phthalates, which are carcinogenic, mutagenic, toxic to reproduction or have endocrine-disrupting properties.

Send them relevant information for this work by 17 July 2023.